BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8586749)

  • 21. Acral melanoma in Japan.
    Seiji M; Takematsu H; Hosokawa M; Obata M; Tomita Y; Kato T; Takahashi M; Mihm MC
    J Invest Dermatol; 1983 Jun; 80 Suppl():56s-60s. PubMed ID: 6343519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
    PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-varying pattern of recurrence risk for localized melanoma in China.
    Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
    World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
    Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
    J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current management and prognosis of acral lentiginous melanoma.
    Wells KE; Reintgen DS; Cruse CW
    Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.
    Samra S; Sawh-Martinez R; Tom L; Colebunders B; Salameh B; Truini C; Ariyan S; Narayan D
    Ann Plast Surg; 2012 Oct; 69(4):415-7. PubMed ID: 22964672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-pigmented nodular plantar melanoma in 12 Japanese patients.
    Kato T; Tabata N; Suetake T; Tagami H
    Br J Dermatol; 1997 Feb; 136(2):207-11. PubMed ID: 9068733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Biopsy Modality on the Management of Cutaneous Melanoma of the Head and Neck.
    Namin AW; Zitsch RP
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):473-478. PubMed ID: 29110565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.
    Etzkorn JR; Sharkey JM; Grunyk JW; Shin TM; Sobanko JF; Miller CJ
    J Am Acad Dermatol; 2017 Aug; 77(2):341-348. PubMed ID: 28601390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature.
    Baykal C; Atci T; Polat Ekinci A; Buyukbabani N
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):236-240. PubMed ID: 27519285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Gloves-and-socks" melanoma: does histology make a difference?
    Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
    Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
    Søndergaard K
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
    Chang AE; Karnell LH; Menck HR
    Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
    Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
    Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanoma of the head and neck.
    Storm FK; Eilber FR; Morton DL; Clark WH
    Head Neck Surg; 1978; 1(2):123-8. PubMed ID: 755804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
    Bradford PT; Goldstein AM; McMaster ML; Tucker MA
    Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.